The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
ConclusionsTB vaccination would be highly impactful and cost-effective in most LMICs. Further efforts are needed for future development, adoption, and implementation of novel TB vaccines.
Source: PLoS Medicine - Category: Internal Medicine Authors: Allison Portnoy Source Type: research
More News: Epidemiology | Internal Medicine | International Medicine & Public Health | Men | Study | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines | WHO